PARSIPPANY, New Jersey, October 2, 2009
Extremity Medical, LLC announced today the release of the TarsX Intramedullary Midfoot Fusion Device. The TarsX system is a novel, intraosseous fixation device that allows surgeons to create a variety of midfoot arthrodeses in each of the five rays while avoiding complications associated with plates. The TarsX device is designed to lock and maintain the anatomic arch of the foot while delivering significant compression and stability across the joints.
Christopher W. DiGiovanni, MD, Professor and Chief of the Division of Foot and Ankle Surgery in the Department of Orthopaedic Surgery, Brown University/Rhode Island Hospital in Providence, RI, led the design team for this product and commented, “The TarsX system is a very novel intramedullary device designed to expand the armamentarium of Foot and Ankle surgeons when faced with the many challenges associated with reconstructing complex midfoot deformity. The intervention is designed to simplify our approach to an historically difficult foot problem which has never been easy to treat.”
Jamy Gannoe, President and co‐Founder of Extremity Medical, further stated, “The introduction of the TarsX System is an example of Extremity Medical’s commitment to delivering specialized solutions to the difficult challenges faced by extremities surgeons.”
The TarsX Midfoot Fixation System was approved by the FDA in April 2009. The company is commencing the limited release of the product in selected centers across the country.
